BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19020736)

  • 21. Modifiable risk factors in colorectal surgery: central role of surgeon's volume.
    Pata G; Casella C; Nascimbeni R; Cirillo L; Salerni B
    Ann Ital Chir; 2008; 79(6):427-32; discussion 432-3. PubMed ID: 19354037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experience with the use of immunochemotherapy in stage-IV colorectal cancer].
    Grinev MV; Abdusamatov FKh; Pivovarova LP; Golubeva AV
    Vestn Khir Im I I Grek; 1997; 156(3):68-72. PubMed ID: 9324850
    [No Abstract]   [Full Text] [Related]  

  • 23. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer.
    Cheung WY; Neville BA; Earle CC
    Dis Colon Rectum; 2009 Jun; 52(6):1054-63; discussion 1064. PubMed ID: 19581846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Estimation of treatment results and side-effects in patients with invasive uterine cervix cancer stage IIB-IVA treated with concurrent radiochemotherapy].
    Torbé B
    Ann Acad Med Stetin; 2008; 54(1):28-40. PubMed ID: 19127807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial.
    Ackerstaff AH; Balm AJ; Rasch CR; de Boer JP; Wiggenraad R; Rietveld DH; Gregor RT; Kröger R; Hilgers FJ
    Head Neck; 2009 Jan; 31(1):77-84. PubMed ID: 18972429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant treatment of colorectal cancer.
    Beretta GD; Milesi L; Pessi MA; Mosconi S; Labianca R
    Surg Oncol; 2004; 13(2-3):63-73. PubMed ID: 15572088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603.
    Kanemitsu Y; Kato T; Shimizu Y; Inaba Y; Shimada Y; Nakamura K; Sato A; Moriya Y;
    Jpn J Clin Oncol; 2009 Jun; 39(6):406-9. PubMed ID: 19389795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
    Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
    Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
    Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at risk of carcinomatosis: preliminary experience of a single centre].
    Virzi S; Iusco D; Grassi A; Navarra G; Ismail I; Panetta A; Bonomi S
    Chir Ital; 2008; 60(6):825-30. PubMed ID: 19256273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.
    Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):436-41. PubMed ID: 19394162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection.
    Søreide K; Slewa A; Stokkeland PJ; van Diermen B; Janssen EA; Søreide JA; Baak JP; Kørner H
    Cancer; 2009 Jan; 115(2):271-82. PubMed ID: 19109816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapse patterns and related prognostic factors in patients with mobile tongue cancer treated with postoperative radiotherapy.
    Kamer S; Esassolak M; Demirci S; Akyildiz S; Sengul A; Yavuzer A
    J BUON; 2009; 14(1):51-6. PubMed ID: 19373947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors.
    Mabuchi S; Morishige K; Isohashi F; Yoshioka Y; Takeda T; Yamamoto T; Yoshino K; Enomoto T; Inoue T; Kimura T
    Gynecol Oncol; 2009 Dec; 115(3):482-7. PubMed ID: 19783286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.
    Buhmeida A; Hilska M; Elzagheid A; Laato M; Collan Y; Syrjänen K; Pyrhönen S
    Anticancer Res; 2009 Jan; 29(1):99-106. PubMed ID: 19331138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term postoperative adjuvant chemotherapy of UFT/LV improves survival in a primary tumor resection-pulmonary metastasis model.
    Sadahiro S; Suzuki T; Maeda Y; Tanaka A; Makuuchi H; Kamijo A; Murayama C
    Anticancer Res; 2008; 28(4B):2045-8. PubMed ID: 18751373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of microsatellite instability and lymphocytic infiltrate as a prognostic indicator for adjuvant therapy in colon cancer.
    Kumar S; Chang EY; Frankhouse J; Dorsey PB; Lee RG; Johnson N
    Arch Surg; 2009 Sep; 144(9):835-40. PubMed ID: 19797108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.